Diphenhydramine Hcl Oral Solution
Product Images NDC 57237-317

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diphenhydramine Hcl Oral Solution (NDC 57237-317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diphenhydramine-case-lab (Diphenhydramine Case Lab)

FDA Label Image

Diphenhydramine-lid-lab (Diphenhydramine Lid Lab)

Diphenhydramine-lid-lab (Diphenhydramine Lid Lab)
This text appears to be a description of an oral solution of Diphenhydramine HCI. The solution contains 12.5 mg of Diphenhydramine HCI per 5 mL. It is meant for institutional use only and is distributed by Rising Pharma Holdings, Inc. The expiration date, lot number, and address of the distributor are also provided. The release date of this product is 12/2023.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.